IP Library Granted Patent US 11,286,282
Granted Patent B2
US 11,286,282 · App. 16/662,784 · Granted Mar 29, 2022

Methods of detection and removal of rhabdoviruses from cell lines

Inventor: Joel R. Haynes (Cambridge, MA)
Assignee: Takeda Vaccines, Inc.
C07K14/005A61K39/205C07K1/14C12N7/00C12Q1/701A61K2039/5258C12N2760/20021C12N2760/20023C12N2760/20034C12N2760/20051C12N2760/20052C12N2770/16023C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,286,282
App. No.
16/662,784
Granted
Mar 29, 2022
Kind
B2
Abstract

The present disclosure relates to compositions, methods, mixtures, and kits for detecting the presence of, and for removing, a virus from a product produced in an insect cell. The disclosure also relates to proteins, peptides, polypeptides, drug substances, biological products, vaccine antigens, and virus-like particles that are produced in an insect cell and that are free or substantially free of a virus. The disclosure also relates to compositions, methods, assays, and kits for detecting a rhabdovirus in a sample.

Claims (8)

1. A rhabdovirus-free Sf9 or Sf21 insect cell comprising a biological product.

2. The insect cell of claim 1 , wherein the insect cell is free of a nucleotide sequence having at least 70% homology to SEQ ID NO:1.

3. The insect cell of claim 1 , wherein the insect cell is an Sf9 cell.

4. The insect cell of claim 3 , wherein the Sf9 cell is derived from the cell line deposited as ATCC CRL-1711.

5. The insect cell of claim 1 , wherein the biological product is a protein, peptide, drug substance, virus-like particle (VLP), DNA, RNA, virus, or vaccine antigen.

6. The insect cell of claim 1 , wherein the biological product is a recombinant virus for gene therapy.

7. The insect cell of claim 1 , wherein the biological product is a protein or virus-like particle (VLP).

8. The insect cell of claim 1 , wherein the insect cell is free of a nucleotide sequence comprising the sequence according to SEQ ID NO: 1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2019
From: HAYNES, JOEL R.
To: TAKEDA VACCINES, INC.
Reel/Frame 050818/0771 →
Continuity (3)
Continuation 15026719
Provisional Application 61886438 · Oct 3, 2013
Related Publication 20200190146A1 · Jun 18, 2020
Cited By (1)
US 12,479,891